Surgical Outcomes in Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis–Related Liver Disease

Patients with chronic liver disease have a higher surgical risk compared with those without. For patients with inflammatory bowel disease (IBD), literature has shown that earlier surgical intervention for those with severe IBD has led to better outcomes regarding mortality and remission. For patients who have both IBD and chronic liver disease, management can be complex. The outcomes in this population of patients who undergo surgical intervention have not been thoroughly explored. This case series aims to evaluate surgical outcomes in patients with a diagnosis of both IBD and primary sclerosing cholangitis chronic liver disease.

Authors

Institutions

Publication Details

Journal
ACG Case Reports Journal
Published
2024-09-27
DOI
https://doi.org/10.14309/crj.0000000000001506
Primary Topic
Liver Diseases and Immunity
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Surgical Outcomes in Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis–Related Liver Disease

Florence-Damilola Odufalu, Taaj Raasikh, Sarah J Wang
ACG Case Reports Journal
Liver Diseases and Immunity
article

Surgical Outcomes in Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis–Related Liver Disease

Florence-Damilola Odufalu, Taaj Raasikh, Sarah J Wang
article en

Abstract

Patients with chronic liver disease have a higher surgical risk compared with those without. For patients with inflammatory bowel disease (IBD), literature has shown that earlier surgical intervention for those with severe IBD has led to better outcomes regarding mortality and remission. For patients who have both IBD and chronic liver disease, management can be complex. The outcomes in this population of patients who undergo surgical intervention have not been thoroughly explored. This case series aims to evaluate surgical outcomes in patients with a diagnosis of both IBD and primary sclerosing cholangitis chronic liver disease.

ACG Case Reports JournalVol. 11(10)
University of Southern California (US), Los Angeles Medical Center (US)
Bristol-Myers Squibb, Pfizer
Openalex Percentile: Top 73%
Liver Diseases and Immunity
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.